Double Bond Pharmaceutical International AB

Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The company's business focus is on the treatment of cancer, infections and autoimmune diseases. The research is based on the company's proprietary drug-delivery technology. The products are sold under separate brands and product development collaborations take place with other players in the industry. The company is headquartered in Uppsala.

Quotes for Double Bond Pharmaceutical International AB

Board

CEO

Igor Lokot

Chairperson of the Board

Sanna Rejnlander

Board

Igor Lokot
Irina Zaitseva
Sergey Yanitsky

Articles of association

Videos

1 / 4

Sitdown Double Bond sitdown

CompanyPresentation BeloGal® and SA-033 (svenska)

CompanyPresentation BeloGal® and SA-033 (english)

CompanyPresentation Aktiespararna intervjuar VD Igor Lokot

** Powered by Modular Finance

*Powered by Modular Finance

Key Numbers

	2026-03-31	2025-12-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Number of months that the report spans	Q1 3 Months	2025	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months	2024
Total revenue MSEK	0.05	0.08	0.02	0.06	0.00	0.00	1.09
Earnings before interest and tax MSEK	-0.27	-1.69	-0.46	-0.47	-0.37	-0.40	-7.76
Profit before tax MSEK	-0.27	-0.33	1.68	-0.47	-0.44	-1.10	-13.24
Net profit MSEK	-0.27	-0.33	1.68	-0.47	-0.44	-1.10	-13.24
Earnings per share SEK	0.00	0.00	0.01	-0.01	-0.01	-0.01	-0.13
Dividend per share SEK	0,00	0.00	0.00	0,00	0,00	0,00	0.00
Equity MSEK	13.91	14.21	14.21	11.53	2.46	2.90	-2.13
Fixed assets MSEK	0.01	0.02	0.02	0.04	0.05	0.07	0.09
Intangible assets MSEK	14.33	12.49	12.49	10.88	9.56	7.94	0.10
Current assets MSEK	2.06	4.17	4.17	2.99	1.97	3.76	5.60
Total asset MSEK	16.40	16.69	16.69	13.90	11.58	11.76	6.22
Long term liabilities MSEK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current liabilities MSEK	2.49	2.48	2.48	2.37	9.12	8.86	8.35
Number of shares SEK	214302697.00	205755688.00	205755688.00	205755688.00	107120108.00	107120108.00	107120108.00